カテゴリー： 世界, 医療/バイオ, Research Dive

世界のハイドロコロイドドレッシング市場2022年-2031年：用途別（急性創傷、慢性創傷、褥瘡）、エンドユーザー別（病院＆診療所、在宅医療、診断クリニック）

【英語タイトル】Hydrocolloid Dressing Market by Application (Acute Wound, Chronic Wound, and Pressure Wound), and End User (Hospitals & Clinics, Home Care Settings, and Diagnostic Clinics): Global Opportunity Analysis and Industry Forecast, 2022-2031

Research Diveが出版した調査資料（RDV23MA021）・商品コード：RDV23MA021
・発行会社（調査会社）：Research Dive
・発行日：2022年12月28日
・ページ数：250
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：生命科学
◆販売価格オプション（消費税別）
Single UserUSD5,700 ⇒換算￥866,400見積依頼/購入/質問フォーム
5 UserUSD8,700 ⇒換算￥1,322,400見積依頼/購入/質問フォーム
Enterprise UserUSD10,700 ⇒換算￥1,626,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Research Dive社の本調査レポートでは、世界のハイドロコロイドドレッシング市場規模が2021年2,349.1百万ドルから2031年には4,725.9百万ドルに達し、年平均7.5%成長すると予測しています。本レポートは、ハイドロコロイドドレッシングの世界市場について調査を行い、調査手法、調査範囲、エグゼクティブサマリー、市場概要、用途別（急性創傷、慢性創傷、褥瘡）分析、エンドユーザー別（病院＆診療所、在宅医療、診断クリニック）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、競争状況などの項目をまとめています。なお、企業情報には、Smith Nephew, 3M, Coloplast Corp, Convatec Inc, Cardinal Health, Molnlycke, Inc., INTEGRA, Abbott, Ltd., Medtronic, and Cardinal Health.などが含まれています。
・調査手法
・調査範囲
・エグゼクティブサマリー
・市場概要
・世界のハイドロコロイドドレッシング市場規模：用途別
- 急性創傷用ハイドロコロイドドレッシングの市場規模
- 慢性創傷用ハイドロコロイドドレッシングの市場規模
- 褥瘡用ハイドロコロイドドレッシングの市場規模
・世界のハイドロコロイドドレッシング市場規模：エンドユーザー別
- 病院＆診療所における市場規模
- 在宅医療における市場規模
- 診断クリニックにおける市場規模
・世界のハイドロコロイドドレッシング市場規模：地域別
- 北米のハイドロコロイドドレッシング市場規模
- ヨーロッパのハイドロコロイドドレッシング市場規模
- アジア太平洋のハイドロコロイドドレッシング市場規模
- 中南米のハイドロコロイドドレッシング市場規模
- 中東/アフリカのハイドロコロイドドレッシング市場規模
・競争状況
・企業情報

As per the analysis by Research Dive, the global hydrocolloid dressing market is expected to register revenue of $4,725.9 million by 2031, growing from $2,349.1 million in 2021, at a CAGR of 7.5%.

COVID-19 Impact on Global Hydrocolloid Dressing Market:
The COVID-19 pandemic has had a negative impact on the global hydrocolloid dressing market. Several organizations around the world were forced to shut down as a result of the COVID-19 pandemic, resulting in massive financial losses. The closure of manufacturing facilities, issues with the supply chain, and the global economic slowdown ultimately had an impact on the hydrocolloid dressing industry. People who had chronic wounds including pressure ulcers, diabetic ulcers, and venous insufficiency ulcers were among those who were most severely impacted by the pandemic as these kinds of wounds needed routine care in order to speed up the healing process. The COVID-19 pandemic and the resulting restrictions, such as self-quarantine or public lockdown, made it difficult to care for patients with chronic wounds. Individuals with chronic wounds are more prone to have a severe course following COVID-19 infection because of their higher age and multiple comorbidities. Also, nonhealing wounds that go untreated and unmanaged due to the lack of easily available wound care solutions can lead to health issues such as infection, sepsis, the requirement for limb amputation, and even death.

Hydrocolloid Dressing Market Analysis:
Wound healing is a dynamic and complex process that requires an appropriate environment to aid healing. With technological innovation, different items such as hydrocolloid dressing have been produced to treat various types of wounds by targeting various components of the healing process. Hydrocolloid dressings are occlusive, preserving wound exudate and encouraging the moist environment required for wound healing. They also induce autolytic wound debridement, which removes necrotic tissue from the wound bed, which is a barrier to wound healing. Environments around wounds that are wet or moist encourage re-epithelialization, lessen inflammatory responses, and prevent the creation of scars. By preserving growth factors and facilitating the production of granulation tissue and epithelization, hydrocolloid dressings also aid in the healing of wounds. These factors are anticipated to boost the hydrocolloid dressing market growth during the forecast period.

Hydrocolloid dressings should be avoided by health practitioners for treating dry and high exudate wounds. Hydrocolloids with a waterproof backing are not suggested for use in clinically infected wounds due to their semi-occlusive nature. Prolonged usage of hydrocolloids in moderately to highly leaking wounds may result in hyper granulation. When using hydrocolloids for an extended period, it is essential to perform regular wound tissue assessments to ensure that hydrocolloid dressings are removed before hyper granulation begins. Some studies recommend against using hydrocolloids in diabetic foot ulcers as they may promote the growth of anaerobic bacteria.

The development of hydro conductive dressing is one of the most recent trends that is projected to gain traction in the hydrocolloid dressing industry in the coming years. A hydrocolloid dressing is regarded as a novel class product because it has a capillary action that lifts and transports exudate while remaining away from the wound surface level. The hydrocolloid process disperses the covering’s contents, allowing additional layers to be applied to more severely exuding sores. The bandage also includes hydrocolloid debridement, which lifts and releases adherent slough that has not been absorbed by the dressing, allowing it to flow toward the dressing for simple removal when the dressing is changed.
By application, the chronic wounds segment is predicted to witness the fastest growth rate.
Chronic wounds are those whose normal healing process has been impeded at one or more locations by hemostasis, inflammation, proliferation, or remodeling. According to medical assessment, using hydrocolloid dressing to treat chronic wounds drastically improves the patient’s condition. All of these factors are expected to increase the hydrocolloid dressing market share.

By end user, the hospitals and clinics segment is anticipated to have a dominant market share due to the increase in the flow of patients who are suffering from acute and chronic wounds where hydrocolloid dressing is required for effective treatment.

By geographical scope, North America dominates the hydrocolloid dressing market in terms of market share and revenue, and this dominance is expected to continue during the forecast period. This is due to the current advanced level of healthcare facilities, as well as the rise in the prevalence of target diseases.
Companies involved in the global hydrocolloid dressing market are Smith Nephew, 3M, Coloplast Corp, Convatec Inc, Cardinal Health, Molnlycke, Inc., INTEGRA, Abbott, Ltd., Medtronic, and Cardinal Health.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1.Research Methodology

1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.5.Market size estimation

1.5.1.Top-down approach
1.5.2.Bottom-up approach

2.Report Scope

2.1.Market Definition
2.2.Key objectives of the study
2.3.Report Overview
2.4.Market segmentation
2.5.Overview of the impact of COVID-19 on the global Hydrocolloid Dressing market

3.Executive Summary

4.Market Overview

4.1.Introduction
4.2.Growth impact forces

4.2.1.Drivers
4.2.2.Restraints
4.2.3.Opportunities

4.3.Market value chain analysis

4.3.1.List of raw material suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors

4.4.Innovation & sustainability matrices

4.4.1.Technology matrix
4.4.2.Regulatory matrix

4.5.Porter’s five forces analysis

4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity

4.6.PESTLE analysis

4.6.1.Political
4.6.2.Economical
4.6.3.Social
4.6.4.Technological
4.6.5.Environmental

4.7.Impact of COVID-19 on Hydrocolloid Dressing market

4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario

5.Hydrocolloid Dressing Market , by Application

5.1.Overview
5.2.Acute Wound

5.2.1.Definition, key trends, growth factors, and opportunities
5.2.2.Market size analysis, by region
5.2.3.Market share analysis, by country

5.3.Chronic Wound

5.3.1.Definition, key trends, growth factors, and opportunities
5.3.2.Market size analysis, by region
5.3.3.Market share analysis, by country

5.4.Pressure Wound

5.4.1.Definition, key trends, growth factors, and opportunities
5.4.2.Market size analysis, by region
5.4.3.Market share analysis, by country

5.5.Research Dive Exclusive Insights

5.5.1.Market attractiveness
5.5.2.Competition heatmap

6.Hydrocolloid Dressing Market, by End User

6.1.Hospitals & Clinics

6.1.1.Definition, key trends, growth factors, and opportunities
6.1.2.Market size analysis, by region
6.1.3.Market share analysis, by country

6.2.Care Settings

6.2.1.Definition, key trends, growth factors, and opportunities
6.2.2.Market size analysis, by region
6.2.3.Market share analysis, by country

6.3.Diagnostic Clinics

6.3.1.Definition, key trends, growth factors, and opportunities
6.3.2.Market size analysis, by region
6.3.3.Market share analysis, by country

6.4.Research Dive Exclusive Insights

6.4.1.Market attractiveness
6.4.2.Competition heatmap

7.Hydrocolloid Dressing Market, by Region

7.1.North America

7.1.1.U.S.

7.1.1.1.Market size analysis, by Application
7.1.1.2.Market size analysis, by End User

7.1.2.Canada

7.1.2.1.Market size analysis, by Application
7.1.2.2.Market size analysis, by End User

7.1.3.Mexico

7.1.3.1.Market size analysis, by Application
7.1.3.2.Market size analysis, by End User
7.1.4.Research Dive Exclusive Insights

7.1.4.1.Market attractiveness
7.1.4.2.Competition heatmap

7.2.Europe

7.2.1.Germany

7.2.1.1.Market size analysis, by Application
7.2.1.2.Market size analysis, by End User

7.2.2.UK

7.2.2.1.Market size analysis, by Application
7.2.2.2.Market size analysis, by End User

7.2.3.France

7.2.3.1.Market size analysis, by Application
7.2.3.2.Market size analysis, by End User

7.2.4.Spain

7.2.4.1.Market size analysis, by Application
7.2.4.2.Market size analysis, by End User

7.2.5.Italy

7.2.5.1.Market size analysis, by Application
7.2.5.2.Market size analysis, by End User

7.2.6.Rest of Europe

7.2.6.1.Market size analysis, by Application
7.2.6.2.Market size analysis, by End User

7.2.7.Research Dive Exclusive Insights

7.2.7.1.Market attractiveness
7.2.7.2.Competition heatmap

7.3.Asia-Pacific

7.3.1.China

7.3.1.1.Market size analysis, by Application
7.3.1.2.Market size analysis, by End User

7.3.2.Japan

7.3.2.1.Market size analysis, by Application
7.3.2.2.Market size analysis, by End User

7.3.3.India

7.3.3.1.Market size analysis, by Application
7.3.3.2.Market size analysis, by End User

7.3.4.Australia

7.3.4.1.Market size analysis, by Application
7.3.4.2.Market size analysis, by End User

7.3.5.South Korea

7.3.5.1.Market size analysis, by Application
7.3.5.2.Market size analysis, by End User

7.3.6.Rest of Asia Pacific

7.3.6.1.Market size analysis, by Application
7.3.6.2.Market size analysis, by End User

7.3.7.Research Dive Exclusive Insights

7.3.7.1.Market attractiveness
7.3.7.2.Competition heatmap

7.4.LAMEA

7.4.1.Brazil

7.4.1.1.Market size analysis, by Application
7.4.1.2.Market size analysis, by End User

7.4.2.Saudi Arabia

7.4.2.1.Market size analysis, by Application
7.4.2.2.Market size analysis, by End User

7.4.3.UAE

7.4.3.1.Market size analysis, by Application
7.4.3.2.Market size analysis, by End User

7.4.4.South Africa

7.4.4.1.Market size analysis, by Application
7.4.4.2.Market size analysis, by End User

7.4.5.Rest of LAMEA

7.4.5.1.Market size analysis, by Application
7.4.5.2.Market size analysis, by End User

7.4.6.Research Dive Exclusive Insights

7.4.6.1.Market attractiveness
7.4.6.2.Competition heatmap

8.Competitive Landscape

8.1.Top winning strategies, 2021

8.1.1.By strategy
8.1.2.By year

8.2.Strategic overview

8.3.Market share analysis, 2021

9.Company Profiles

9.1.3M

9.1.1.Overview
9.1.2.Business segments
9.1.3.Product portfolio
9.1.4.Financial performance
9.1.5.Recent developments
9.1.6.SWOT analysis

9.2.Smith Nephew

9.2.1.Overview
9.2.2.Business segments
9.2.3.Product portfolio
9.2.4.Financial performance
9.2.5.Recent developments
9.2.6.Coloplast Corp

9.3.Methanex Corporation

9.3.1.Overview
9.3.2.Business segments
9.3.3.Product portfolio
9.3.4.Financial performance
9.3.5.Recent developments
9.3.6.SWOT analysis

9.4.Convatec Inc

9.4.1.Overview
9.4.2.Business segments
9.4.3.Product portfolio
9.4.4.Financial performance
9.4.5.Recent developments
9.4.6.SWOT analysis

9.5.Cardinal Health

9.5.1.Overview
9.5.2.Business segments
9.5.3.Product portfolio
9.5.4.Financial performance
9.5.5.Recent developments
9.5.6.SWOT analysis

9.6.Molnlycke

9.6.1.Overview
9.6.2.Business segments
9.6.3.Product portfolio
9.6.4.Financial performance
9.6.5.Recent developments
9.6.6.SWOT analysis

9.7.INTEGRA

9.7.1.Overview
9.7.2.Business segments
9.7.3.Product portfolio
9.7.4.Financial performance
9.7.5.Recent developments
9.7.6.SWOT analysis

9.8.Abbott

9.8.1.Overview
9.8.2.Business segments
9.8.3.Product portfolio
9.8.4.Financial performance
9.8.5.Recent developments
9.8.6.SWOT analysis

9.9.Medtronic,

9.9.1.Overview
9.9.2.Business segments
9.9.3.Product portfolio
9.9.4.Financial performance
9.9.5.Recent developments
9.9.6.SWOT analysis

9.10.Cardinal Health

9.10.1.Overview
9.10.2.Business segments
9.10.3.Product portfolio
9.10.4.Financial performance
9.10.5.Recent developments
9.10.6.SWOT analysis



★調査レポート[世界のハイドロコロイドドレッシング市場2022年-2031年：用途別（急性創傷、慢性創傷、褥瘡）、エンドユーザー別（病院＆診療所、在宅医療、診断クリニック）] (コード：RDV23MA021)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のハイドロコロイドドレッシング市場2022年-2031年：用途別（急性創傷、慢性創傷、褥瘡）、エンドユーザー別（病院＆診療所、在宅医療、診断クリニック）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のフォームドレッシング市場2023年-2032年：素材別（ポリウレタン、シリコーン）、用途別（慢性創傷、急性創傷）、エンドユーザー別（病院、在宅医療、その他）
  • 世界の高度創傷治療市場2023年-2032年：製品別（感染管理、滲出液管理、積極的創傷治療、治療機器）、用途別（慢性創傷、急性創傷）、エンドユーザー別（病院、在宅医療、その他）
  • 世界の酵素による創傷デブリードマン市場2023-2030：種類別（慢性創傷、急性創傷）、製品別（パパイン製品、コラゲナーゼ製品、その他）、エンドユーザー別（病院、在宅医療、その他）、地域別
  • 世界の先進創傷ケア市場2024-2030：製品別（湿潤、抗菌）、用途別（慢性創傷、急性創傷）、エンドユーザー別（病院、専門クリニック、在宅医療）、地域別
  • 世界の抗菌性創傷ケアドレッシング市場2023-2030：製品別（銀ドレッシング、ポビドンヨードドレッシング、PHMBドレッシング、その他）、用途別（慢性創傷、急性創傷）、エンドユーザー別（病院、外来患者施設、在宅医療、研究＆製造）、地域別
  • 世界のインタラクティブ創傷被覆材市場2023-2030：製品別（半透過性フィルム、半透過性フォーム、ドレッシング、ハイドロゲルドレッシング）、用途別（慢性創傷、急性創傷）、エンドユーザー別（病院、外来患者施設、在宅医療、研究＆製造）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆